Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Acute Lymphoblastic Leukemia
87%
Israel
51%
Leukemia
43%
Bone Marrow
26%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
26%
Tumor
24%
Acute Myeloid Leukemia
24%
Working Diagnosis
22%
Berlin
21%
Frankfurt
20%
Pediatric
19%
Event-free Survival
19%
Neuroblastoma
18%
TP53 mutation
18%
Israeli
18%
Chemotherapy
17%
Relapsed or Refractory Acute Myeloid Leukemia
17%
Treatment Protocol
17%
Down Syndrome
16%
Improved Outcomes
16%
Methotrexate
16%
Flow Cytometry
15%
Leukemic Cells
15%
Langerhans Cell Histiocytosis
14%
Minimal Residual Disease
14%
Spectral Karyotyping
14%
Hemophagocytic Lymphohistiocytosis
14%
Germ Cells
14%
Fluorescence in Situ Hybridization
14%
Acute Leukemia
12%
Leukemia Patients
12%
Prognostic Significance
12%
B Cells
12%
Immunophenotyping
12%
High Dose
12%
Aberrations
12%
Complete Remission
11%
Trisomy 21
11%
Clonal Evolution
11%
Central Nervous System
11%
B-lineage
11%
Overall Survival
11%
MYCN Amplification
10%
Intrathecal Drug Delivery
9%
ATM Gene
9%
Ewing Sarcoma Family of Tumors
9%
Bedouin
9%
Hodgkin Disease
9%
Rhabdomyosarcoma
9%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
92%
Acute Myeloid Leukemia
42%
Leukemia
38%
Diseases
30%
Pediatrics
29%
Central Nervous System
21%
Event Free Survival
20%
Precursor
17%
Leukemia in Children
17%
Neoplasm
16%
Overall Survival
15%
Langerhans Cell Histiocytosis
14%
Down Syndrome
14%
B Cell
13%
Flow Cytometry
13%
Malignant Neoplasm
12%
Prognostic Factor
12%
High Risk Population
12%
Methotrexate
11%
Infancy
11%
Acute Myelogenous Leukemia
11%
Acute B-Cell Lymphoblastic Leukemia
9%
B-Cell Lymphoma
9%
Hemophagocytic Syndrome
9%
Myeloid Leukemia
9%
Survival Rate
9%
Blast Cell
9%
Minimal Residual Disease
9%
Prednisone
9%
Karyotype
8%
Retrospective Study
8%
Myeloid Cell
8%
Radiation Therapy
8%
Immunophenotyping
8%
Bone Marrow Transplantation
8%
Leukocyte
7%
Drug Megadose
7%
Differential Diagnosis
7%
Lymphoid Leukemia
7%
Acute Leukemia
7%
Monoclonal Antibody
7%
Monosomy 7
6%
Hematopoietic Cell
6%
T Cell
6%
Cyclophosphamide
6%
Cumulative Incidence
6%
Myelodysplastic Syndrome
6%
Recurrent Disease
6%
Trisomy 21
6%
Immunoglobulin
6%